Dynamic carbon 13 breath tests for the study of liver function and gastric emptying

Gastroenterology Report

Volumn 3, Issue 1, 2015, Pages 12-21

  Bonfrate, Leonilde ^a   Grattagliano, Ignazio ^b   Palasciano, Giuseppe ^a   Portincasa, Piero ^a  

^a UNIVERSITY OF BARI   (Italy)

^b Florence and Bari   (Italy)

Author keywords

Breath tests; Gastric motility; Hepatic metabolism; Scintigraphy; Stable isotope

Indexed keywords

EID: 84977983137     PISSN: None     EISSN: 20520034     Source Type: Journal    
DOI: 10.1093/gastro/gou068     Document Type: Review

References (76)

1. Gasbarrini A, Corazza GR, Gasbarrini G et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009;29 Suppl 1:1-49.
2. Sherlock S and Dooley J. Diseases of the liver and biliary system. Oxford: Blackwell Science, 2002:597-628.
3. Sakka SG. Assessing liver function. Curr Opin Crit Care 2007;13:207-14.
4. Grattagliano I, Lauterburg BH, Palasciano G et al. 13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest 2010;40:843-50.
5. Merkel C, Bolognesi M, Bellon S et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992;33:836-42.
6. Miele L, Marrone G, Cefalo C et al. Potential use of liver function breath tests in the clinical practice. Eur Rev Med Pharmacol Sci 2013;17 Suppl 2:82-9.
7. Giannini E, Fasoli A, Chiarbonello B et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2002;16:717-25.
8. Armuzzi A, Candelli M, Zocco MA et al. Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther 2002;16:1977-96.
9. Michaletz PA, Cap L, Alpert E et al. Assessment of mitochondrial function in vivo with a breath test utilizing alpha-ketoisocaproic acid. Hepatology 1989;10:829-32.
10. Burke PA, Stack JA, Wagner D et al. L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg 1997;173:270-4.
11. Lara Baruque S, Razquin M, Jimenez I et al. 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis 2000;32:226-32.
12. Zhang GS, Bao ZJ, Zou J et al. Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases. BMC Geriatr 2010;10:23.
13. Festi D, Capodicasa S, Sandri L et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels. World J Gastroenterol 2005;11:142-8.
14. Shreeve WW, Shoop JD, Ott DG et al. Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2. Gastroenterology 1976;71:98-101.
15. Giannini EG, Fasoli A, Borro P et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol 2005;3:279-85.
16. Saadeh S, Behrens PW, Parsi MA et al. The utility of the 13Cgalactose breath test as a measure of liver function. Aliment Pharmacol Ther 2003;18:995-1002.
17. Giannini E, Botta F, Borro P et al. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection. Am J Gastroenterol 2003;98:2516-20.
18. Rocco A, de Nucci G, Valente G et al. 13C-aminopyrine breath test accurately predicts long-term outcome of chronic hepatitis C. J Hepatol 2012;56:782-7.
19. Schneider AR, Teuber G, Paul K et al. Patient age is a strong independent predictor of 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection. Clin Exp Pharmacol Physiol 2006;33:300-4.
20. Opekun AR, Jr., Klein PD and Graham DY. [13C]Aminopyrine breath test detects altered liver metabolism caused by lowdose oral contraceptives. Dig Dis Sci 1995;40:2417-22.
21. Brockmoller J, Roots I. Assessment of liver metabolic function. Clinical implications. Clin Pharmacokinet 1994;27:216-48.
22. Ciccocioppo R, Candelli M, Di Francesco D et al. Study of liver function in healthy elderly subjects using the 13C-methacetin breath test. Aliment Pharmacol Ther 2003;17:271-7.
23. Klatt S, Taut C, Mayer D et al. Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol 1997;35:609-14.
24. Liu YX, Huang LY, Wu CR et al. Measurement of liver function for patients with cirrhosis by 13C-methacetin breath test compared with Child-Pugh score and routine liver function tests. Chin Med J (Engl) 2006;119:1563-6.
25. Zipprich A, Meiss F, Steudel N et al. 13C-Methacetin metabolism in patients with cirrhosis: relation to disease severity, haemoglobin content and oxygen supply. Aliment Pharmacol Ther 2003;17:1559-62.
26. Koda M, Matunaga Y, Kawakami M et al. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007;45:297-306.
27. Dinesen L, Caspary WF, Chapman RW et al. 13C-methacetinbreath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis 2008;40:743-8.
28. Parra D, Gonzalez A, Mugueta C et al. Laboratory approach to mitochondrial diseases. J Physiol Biochem 2001;57:267-84.
29. Lauterburg BH, Liang D, Schwarzenbach FA et al. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology 1993;17:418-22.
30. Witschi A, Mossi S, Meyer B et al. Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res 1994;18:951-5.
31. Portincasa P, Grattagliano I, Lauterburg BH et al. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006;111:135-43.
32. Palmieri VO, Grattagliano I, Minerva F et al. Liver function as assessed by breath tests in patients with hepatocellular carcinoma. J.Surg.Res. 2009;157:199-207.
33. Bonfrate L, Giuliante F, Palasciano G et al. Unexpected discovery of massive liver echinococcosis. A clinical, morphological, and functional diagnosis. Ann Hepatol 2013;12:634-41.
34. Pessayre D, Mansouri A, Haouzi D et al. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999;15:367-73.
35. Pessayre D, Fromenty B, Berson A et al. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 2012;44:34-87.
36. Gabe SM, Bjarnason I, Tolou-Ghamari Z et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 1998; 115:67-74.
37. Sternfeld T, Lorenz A, Schmid M et al. Increased red cell corpuscular volume and hepatic mitochondrial function in NRTI-treated HIV infected patients. Curr HIV Res 2009;7:336-9.
38. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-37.
39. Armuzzi A, Marcoccia S, Zocco MA et al. Non-invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol 2000;35:650-3.
40. Spahr L, Negro F, Leandro G et al. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit 2003;9:CR6-11.
41. Milazzo L, Piazza M, Sangaletti O et al. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother 2005;55:84-9.
42. Sternfeld T, Lorenz A, Schmid M et al. [(13)C]Methionine breath test as a marker for hepatic mitochondrial function in HIV-infected patients. AIDS Res Hum Retroviruses 2009;25:1243-8.
43. Banasch M, Ellrichmann M, Tannapfel A et al. The noninvasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. Eur J Med Res 2011;16:258-64.
44. Stuwe SH, Goetze O, Arning L et al. Hepatic mitochondrial dysfunction in Friedreich ataxia. BMC Neurol 2011;11:145.
45. Feld JJ, Modi AA, El-Diwany R et al. S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenterology 2011;140:830-9.
46. Shalev T, Aeed H, Sorin V et al. Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models. Dig Dis Sci 2010;55:1589-98.
47. Schneider AR, Kraut C, Lindenthal B et al. Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men. Eur J Gastroenterol Hepatol 2005;17:1181-4.
48. Miele L, Grieco A, Armuzzi A et al. Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 2003;98:2335-6.
49. van de Casteele M, Luypaerts A, Geypens B et al. Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease. Neurogastroenterol Motil 2003;15:113-20.
50. Camilleri M, Parkman HP, Shafi MA et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013;108:18-37.
51. Portincasa P, Moschetta A, Baldassarre G et al. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting the Rome II criteria for irritable bowel. World J Gastroenterology 2003;9:2293-9.
52. Di Ciaula A, Wang DQ, Portincasa P. Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol 2012;27:1298-305.
53. Kuo B, McCallum RW, Koch KL et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008;27:186-96.
54. Ghoos Y, Geypens B, Rutgeerts P. 13CO2 breath tests and stable isotopes for investigating gastrointestinal functions. Acta Gastroenterol.Belg. 2000;63:325-7.
55. Ghoos YF, Maes BD, Geypens BJ et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993;104:1640-7.
56. Maes BD, Geypens BJ, Ghoos YF et al. 13C-Octanoic acid breath test for gastric emptying rate of solids. Gastroenterology 1998;114:856-9.
57. Perri F, Bellini M, Portincasa P et al. (13)C-octanoic acid breath test (OBT) with a new test meal (EXPIROGer): toward standardization for testing gastric emptying of solids. Dig Liver Dis 2010;42:549-53.
58. Perri F, Clemente R, Festa V et al. 13C-octanoic acid breath test: a reliable tool for measuring gastric emptying. Ital J Gastroenterol Hepatol 1998;30:211-17.
59. Perri F, Ghoos YF, Maes BD et al. Gastric emptying and Helicobacter pylori infection in duodenal ulcer disease. Digestive Diseases and Sciences 1996;41:462-8.
60. Lee JS, Camilleri M, Zinsmeister A et al. A valid, accurate, office based, non-radioactive test for gastric emptying of solids. Gut 2000;46:768-73.
61. Bromer MQ, Kantor SB, Wagner DA et al. Simultaneous measurement of gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci 2002;47:1657-63.
62. Choi MG, Camilleri M, Burton DD et al. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 1997;112:1155-62.
63. Duan LP, Braden B, Caspary WF et al. Influence of cisapride on gastric emptying of solids and liquids monitored by 13C breath tests. Dig Dis Sci 1995;40:2200-6.
64. Braden B, Adams S, Duan LP et al. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 1995;108:1048-55.
65. Hellmig S, Von Schöning F, Gadow C et al. Gastric emptying time of fluids and solids in healthy subjects determined by13C breath tests: influence of age, sex and body mass index. J Gastroenterol Hepatol 2006;21:1832-8.
66. Delbende B, Perri F, Couturier O et al. 13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol 2000;12:85-91.
67. Lee JS, Camilleri M, Zinsmeister AR et al. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol 2000;95:2751-61.
68. Viramontes BE, Kim DY, Camilleri M et al. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil 2001;13:567-74.
69. Szarka LA, Camilleri M, Vella A et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008;6:635-43 e1.
70. Bonfrate L, Ruggiero V, Mossel E et al. A novel promising solid test meal to study gastrointestinal kinetics and symptoms in health and disease. A pilot study by functional ultrasonography. European Journal of Clinical Investigation 2014;44:78.
71. Debreceni A, Abdel-Salam OME, Figler M et al. Capsaicin increases gastric emptying rate in healthy human subjects measured by 13C-labeled octanoic acid breath test. J Physiol Paris 1999;93:455-60.
72. Maes BD, Hiele MI, Geypens BJ et al. Pharmacological modulation of gastric emptying rate of solids as measured by the carbon labelled octanoic acid breath test: influence of erythromycin and propantheline. Gut 1994;35:333-7.
73. Maes BD, Ghoos YF, Rutgeerts PJ et al. [C]octanoic acid breath test to measure gastric emptying rate of solids. Dig Dis Sci 1994;39(12 Suppl):104S-6S.
74. Portincasa P and Palasciano G. Breath testing for gastric emptying and intestinal transit evaluation. Gastroenterol Int 1999;12:46-8.
75. Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes 2013;62:2667-73.
76. Choi MG, Camilleri M, Burton DD et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998;93:92-8.